Alberta Hip and Knee Replacement Project

NCT ID: NCT00277186

Last Updated: 2008-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3434 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-04-30

Study Completion Date

2006-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to determine if a New Arthroplasty Care Model, established on evidence-based medicine and best practices, will improve patient outcomes and improve cost effectiveness for patients with severe degenerative joint disease of the hip or knee in Alberta

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Alberta Orthopaedic Society through its Arthroplasty Service Design Working Group has, after carefully reviewing the existing conventional approach to arthroplasty care, developed what they believe could be a much improved new evidence based arthroplasty care model. This model represents how ideally a patient would access and receive health services across the complete continuum of care. In addition, wherever possible, evidence gathered from the literature and from "known best practices" has been utilized to develop standards related to access, wait times, clinical quality, resource use and health outcome measures. Where no evidence or "known best practices" exist, a standard that best support achieving other known standards are being developed. This new evidence based arthroplasty model seeks to significantly minimize and where possible, eliminate all the current gaps and barriers to arthroplasty care.

This study will seek to prove that the new evidence based arthroplasty model will deliver improved patient outcomes with improved cost effectiveness. Once proven, it is anticipated that this new evidence based arthroplasty model will become the standard of care in Alberta, and a model for other jurisdictions to use in their health service re-designs

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthroplasty, Replacement, Hip Arthroplasty, Replacement, Knee

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Arthroplasty Health services research Intent to treat Randomized Controlled

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Patients entering new care continuum

Group Type ACTIVE_COMPARATOR

New Care Continuum

Intervention Type OTHER

Patient experience surgery through newly designed arthroplasty continuum

Control

Patient enter existing conventional approach

Group Type ACTIVE_COMPARATOR

New Care Continuum

Intervention Type OTHER

Patient experience surgery through newly designed arthroplasty continuum

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

New Care Continuum

Patient experience surgery through newly designed arthroplasty continuum

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is at least 18 years of age
* Patient is able to provide written consent

Exclusion Criteria

* Patient has previously undergone arthroplasty of the same hip or knee (revision)
* Patient has a surgical date scheduled for arthroplasty
* Patient requires a hip resurfacing procedure or an oxford knee
* Patient has a concurrent medical condition that would contraindicate the patients' ability to participate fully in the study procedures, including terminal conditions such as chronic obstructive pulmonary disease, end stage renal disease, heart failure, malignancy with an anticipated life expectancy of ≤ 2 years
* Patient has senile dementia or Alzheimer's disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alberta Medical Association

OTHER

Sponsor Role collaborator

Calgary Health Region

OTHER

Sponsor Role collaborator

David Thompson Health Region

UNKNOWN

Sponsor Role collaborator

Capital Health Region

UNKNOWN

Sponsor Role collaborator

Alberta Health & Wellness

OTHER_GOV

Sponsor Role collaborator

Alberta Bone and Joint Health Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alberta Bone and Joint Health Institute

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cyril Frank, MD

Role: PRINCIPAL_INVESTIGATOR

University of Calgary

Bill Johnston, MD

Role: PRINCIPAL_INVESTIGATOR

University of Alberta

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alberta Bone and Joint Health Institute

Calgary, Alberta, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Gooch K, Marshall DA, Faris PD, Khong H, Wasylak T, Pearce T, Johnston DW, Arnett G, Hibbert J, Beaupre LA, Zernicke RF, Frank C. Comparative effectiveness of alternative clinical pathways for primary hip and knee joint replacement patients: a pragmatic randomized, controlled trial. Osteoarthritis Cartilage. 2012 Oct;20(10):1086-94. doi: 10.1016/j.joca.2012.06.017. Epub 2012 Jul 11.

Reference Type DERIVED
PMID: 22796513 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ARTH-00001

Identifier Type: -

Identifier Source: org_study_id